Aisling Capital as of March 31, 2015
Portfolio Holdings for Aisling Capital
Aisling Capital holds 19 positions in its portfolio as reported in the March 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Esperion Therapeutics (ESPR) | 24.9 | $190M | 2.1M | 92.60 | |
| Cempra | 14.8 | $113M | 3.3M | 34.31 | |
| Zeltiq Aesthetics | 10.5 | $80M | 2.6M | 30.83 | |
| Loxo Oncology | 5.6 | $43M | 3.5M | 12.45 | |
| Versartis | 5.5 | $42M | 2.3M | 18.37 | |
| T2 Biosystems | 5.1 | $39M | 2.5M | 15.52 | |
| Chimerix (CMRX) | 5.0 | $39M | 1.0M | 37.69 | |
| Adma Biologics (ADMA) | 4.6 | $35M | 3.6M | 9.80 | |
| Catalent | 4.5 | $35M | 1.1M | 31.15 | |
| Agile Therapeutics | 3.6 | $28M | 3.0M | 9.27 | |
| Transenterix | 3.2 | $24M | 8.3M | 2.93 | |
| Pernix Therapeutics Holdings | 2.8 | $22M | 2.0M | 10.69 | |
| Paratek Pharmaceuticals | 2.8 | $21M | 683k | 31.26 | |
| Sorrento Therapeutics (SRNE) | 2.7 | $20M | 1.8M | 11.56 | |
| Dermira | 2.2 | $17M | 1.1M | 15.35 | |
| Intersect Ent | 1.2 | $9.0M | 350k | 25.83 | |
| Lombard Med (EVARF) | 0.5 | $3.6M | 886k | 4.03 | |
| Roka Bioscience | 0.5 | $3.6M | 1.1M | 3.20 | |
| Mei Pharma | 0.0 | $0 | 0 | 0.00 |
